Juan Gimeno Blanes

Associate Professor

Universidad de Murcia

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Science Medical Science professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Juan Gimeno Blanes is an Associate Professor at Universidad de Murcia, Spain. His research focuses on cardiomyopathies, particularly in relation to hypertrophic cardiomyopathy and atrial fibrillation, as well as the management and outcomes of cardiomyopathies in children and adolescents. He has contributed to recent studies analyzing sudden death cases, the impact of SARS-CoV-2 in patients with hypertrophic cardiomyopathy, and updates on management guidelines for cardiomyopathies.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (19)

Ignacio Martínez-González-Moro

Universidad de Murcia

SPAIN

Juan Gimeno Blanes

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Electrocardiogram May Fail to Identify Proportion of High-Risk Individuals: Analysis of Series of 50 Sudden Death Cases

Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study

2023 ESC Guidelines for the management of cardiomyopathies

Current therapies for hypertrophic cardiomyopathy: a systematic review and meta‐analysis of the literature

Impact of SARS‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.

Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry

Towards an Enhanced Tool for Quantifying the Degree of LV Hyper-Trabeculation

Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences

ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant

Genetic Factors Involved in Cardiomyopathies and in Cancer

Collaborators (19)

Ignacio Martínez-González-Moro

Pawel Rubis

Loira Leoni

Maria Sabater-Molina

Maria Angela LOSI

Gregorio Bernabé

Rudolf de Boer

Iacopo Olivotto

Juan Pablo Kaski

BARBARA BONACASA

Jodie Ingles

Eduardo Villacorta

Róbert Sepp

Leila Rouhi, M.D., Ph.D.

Michal Tendera

Jens Mogensen

Priyatansh Gurha

Morten Kvistholm Jensen

Perry Elliott

Make your next move.